BioSpace News Archive

Business

Thermo Fisher Scientific Declares Quarterly Dividend Payable on January 15, 2019

Thermo Fisher Scientific Inc. today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per common share, payable on January 15, 2019, to shareholders of record as of December 17, 2018.

November 8, 2018
·
1 min read
Business

Akebia Therapeutics Announces Third Quarter 2018 Financial Results

Akebia Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2018.

November 8, 2018
·
14 min read
Pharm Country

Carmell Therapeutics President & CEO, Randy Hubbell, to Present at Investor and MedTech Conferences in November

Carmell Therapeutics today announced its plans to participate in both the 2018 Biotech and Money Investival Showcase and the 2018 MedTech Strategist Innovation Summit.

November 8, 2018
·
2 min read
Business

Cresco Labs Appoints Key Executives And Accelerates Growth Ahead Of Expected Public Listing

Cresco Labs today announced key growth milestones achieved ahead of the company’s expected public listing on the Canadian Securities Exchange (“CSE”).

November 8, 2018
·
3 min read
Business

Celsius Holdings Reports Record Third Quarter 2018 Revenue Growth

Third Quarter Revenue Increased 54% to $16.6 Million

November 8, 2018
·
16 min read
Biotech Beach

NuVasive’s Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure

Company receives FDA 510(k) clearance for use of COHERE® interbody in XLIF® procedure as new clinical study further validates important benefits of Porous PEEK™ material technology

November 8, 2018
·
4 min read
Business

BioLife Solutions Announces Third Quarter 2018 Financial Results

Revenue increases 79% to a record $5.3 million; achieves net income of $1.2 million

November 8, 2018
·
10 min read
Business

CONMED Corporation Announces Quarterly Cash Dividend Payable on January 7, 2019

CONMED Corporation today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 7, 2019 to all shareholders of record as of December 14, 2018.

November 8, 2018
·
2 min read
Business

Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results

Poziotinib interim data from the MD Anderson Phase 2 study presented in Q3 demonstrated strong efficacy in metastatic, heavily pretreated EGFR and HER2 exon 20 mutations in NSCLC patients

November 8, 2018
·
17 min read
Business

Versant Health Expands Its National Sales Team

Versant Heal continues to grow its national sales team with two regional executives: Kristen Gutierrez and Brett Cavallaro.

November 8, 2018
·
1 min read